Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
16.72
+0.20 (1.24%)
Oct 19, 2026, 2:00 PM EDT - Market open
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.02 billion as of October 19, 2026. It is the 10,060th most valuable company in the world and the 2,227th biggest in the United States. Its market cap has decreased by 36.45% in one year.
Market Cap
1.02B
Enterprise Value
71.98M
1-Year Change
-36.45%
Global Rank
Country Rank
#2,227 United States
Category
ChartMarket Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.02B, an increase of 66.51%. That is a compound annual growth rate of 9.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 1.02B | 23.11% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 1.14B |
| Nanobiotix | 1.08B |
| Verastem | 1.08B |
| Vor Biopharma | 1.06B |
| Avalyn Pharma | 1.04B |
| Replimune Group | 1.03B |
| MannKind | 1.01B |
| Immatics | 974.60M |